Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients

Background: Diffuse large B-cell lymphoma (DLBCL) used to be defined as germinal center B-like and non-germinal center B-like subtypes, associated with different prognoses, but the conventional classification does not meet the needs of clinical practice because of DLBCL heterogeneity, a problem that...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Maogui, Wang, Xinchen, Liu, Ning, Ding, Kaiyang, Zhang, Guihong, Liu, Xiaosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239963/
https://www.ncbi.nlm.nih.gov/pubmed/34109978
http://dx.doi.org/10.1042/BSR20201551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239963/
https://www.ncbi.nlm.nih.gov/pubmed/34109978
http://dx.doi.org/10.1042/BSR20201551

Ejemplares similares